A *must-read* for #rheumatologists. Wonderfully written piece by Sara Tedeschi, and wonderful that Peter Grayson played an important role -- two wonderful people I'm so fortunate to know and have the pleasure of working with. Unexpected Closure | NEJM nejm.org/doi/full/10.10…

#BWHRheumatology Dr. Sara Tedeschi (Sara Tedeschi) discusses calcium pyrophosphate deposition disease (#CPPD) epidemiology and pathogenesis on ReachMD's "Living Rheum" podcast. Full interview and transcript linked below: tinyurl.com/mrxt6tt9

#ACR22 1809. Impact of Colchicine Prophylaxis on Cardiovascular Outcome Among Gout Patients: A Secondary Analysis of CARES Trial. No CV benefit with colchicine 6-month prophylaxis. Too short for this benefit? By Keigo Hayashi.

It was great to get together with fellow #Crystaleers in-person outside of the virtual community hubs at #ACR22! Gout-Crystal Arthritis Network

#ACR22 Brigham and Women’s Hospital Rheumatology reunion

First-ever classification criteria for #CPPD. These are joint American College of Rheumatology / EULAR criteria, and are currently in DRAFT status. #ACR22 #ACRambassador

Imaging features of CPPD; adopted established OMERACT CPPD #ultrasound definitions. Ultrasound is more sensitive than XR for dx CPPD. Different appearance than gout. Mass General Brigham Sara Tedeschi Minna Kohler, MD, RhMSUS Stacy E. Smith MD #FJosephSimeoneMD Janeth Yinh #hyonchoidmd #ACR22

Phenomenal presentation by Sara Tedeschi on the Draft ACR/EULAR #CPPD classification criteria today at #ACR22! Can’t wait to see the final published criteria!

Congratulations Medha Barbhaiya for draft ACR/EULAR #APS classification criteria! Taking a lesson from you on best practices for presenting classification methodology!!

Move over gout criteria to make way for pseudogout criteria. Next steps should be finding successful therapies. If you can classify it, you can study it better. Dr. John Cush #ACR22

The 25 Best Gifts for New Moms of 2022 | Reviews by Wirecutter — featuring the one and only ⁦gracefarris⁩ at the top of the list! If this isn’t the pinnacle of success, what is? ⁦Annals of Int Med⁩ Dr. Mom nytimes.com/wirecutter/gif…

A group of international researchers is surveying CPPD (pseudogout) patients and caregivers to figure out which outcomes are essential for future CPPD research studies. Take the surveys by 2/28/23:  ➡️ bit.ly/3WnXTWO  ➡️bit.ly/3IUYmwD

In the latest episode of ACR on Air, guest Sara Tedeschi talks #CPPD, including its diagnosis, creating classification criteria for it, & the best ways to treat it. Tune in & learn more → acronair.org

Calcium Pyrophosphate Dihydrate Deposition: prevalent crystal #arthritis Mass General Brigham #rheumatology experts help dvlp CPPD Classification Criteria to further research efforts onlinelibrary.wiley.com/doi/full/10.10… Sara Tedeschi #HyonKChoiMDPhD Minna Kohler, MD, RhMSUS Janeth Yinh Chio Yokose

CPP crystal arthritis & MACE risk - Sara Tedeschi pubmed.ncbi.nlm.nih.gov/35613842/ #2023GCAN

Sara Tedeschi OMERACT Ann Rosenthal & pyrophosphate updates High level takeaways: ⚡️Too much extracellular ATP ➡️more PPi ➡️more deposition ⚡️ANK: an ATP transporter (not PPi transporter) #2023GCAN

Gout-Crystal Arthritis Network Tuhina Neogi, MD, PhD Work from Sara Tedeschi to be presented as a poster in the crystal section You've seen their work on CPPD & MACE; now here's work on CPPD and fracture x.com/rheum_cat/stat… #ACR23

The #CPPD crew presenting to the largest audience ever for this topic at #ACR23

⁦Sara Tedeschi⁩ 25% increased risk of CV events in people with CPPD. Even higher risk after acute CPP crystal arthritis. Is the explanation vascular calcification, inflammation or combination #ACR23

BRIC Registry of people with CPPD arthritis is going to give some valuable insights into this enigmatic disease into the future. Big crowd here this afternoon! ⁦Sara Tedeschi⁩ #crystalarthritis #ACR23